Chemoinformaics analysis of 1,4-Diaminobutane
Molecular Weight | 88.154 | nRot | 3 |
Heavy Atom Molecular Weight | 76.058 | nRig | 0 |
Exact Molecular Weight | 88.1001 | nRing | 0 |
Solubility: LogS | 1.127 | nHRing | 0 |
Solubility: LogP | -0.971 | No. of Aliphatic Rings | 0 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 2 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 18 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 6 | No. of Aromatic Carbocycles | 0 |
nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 12 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 4 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 2 | No. of Arom Atom | 0 |
No. of Oxygen atom | 0 | No. of Arom Bond | 0 |
nHA | 2 | APOL | 16.8815 |
nHD | 2 | BPOL | 10.8985 |
QED | 0.465 |
Synth | 2.011 |
Natural Product Likeliness | 0.566 |
NR-PPAR-gamma | 0.004 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Rejected |
Pgp-inh | 0.042 |
Pgp-sub | 0.013 |
HIA | 0.052 |
CACO-2 | -6.206 |
MDCK | 0.000365212 |
BBB | 0.343 |
PPB | 0.0834539 |
VDSS | 1.205 |
FU | 0.916189 |
CYP1A2-inh | 0.033 |
CYP1A2-sub | 0.103 |
CYP2c19-inh | 0.021 |
CYP2c19-sub | 0.226 |
CYP2c9-inh | 0.003 |
CYP2c9-sub | 0.168 |
CYP2d6-inh | 0.004 |
CYP2d6-sub | 0.896 |
CYP3a4-inh | 0.005 |
CYP3a4-sub | 0.199 |
CL | 5.637 |
T12 | 0.483 |
hERG | 0.043 |
Ames | 0.055 |
ROA | 0.752 |
SkinSen | 0.882 |
Carcinogencity | 0.112 |
EI | 0.102 |
Respiratory | 0.817 |
NR-Aromatase | 0.01 |
Antiviral | No |
Prediction | 0.960208 |